Vor Biopharma is developing telitacicept, an investigational treatment for autoimmune diseases. It last closed at $19.19 on Nov 20, up 3.62% on the day. For the quarter ended Sep 2026, VOR reported EPS of -$1.45. Over the last 12 months VOR insiders bought $0 of stock on the open market and sold $49.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is VOR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VOR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on VORStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
VOR · as of the Nov 20 close · updated each morning
Moving sideways
The stock is 1% below its 20 day and 2% below its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 49). The nearest support is the Pivot at $19.04, and the nearest resistance the 20 day average at $19.40.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.7%/day
Key levels
$26.0052 week high+35.5%
$20.55100 day average+7.1%
$20.08Pivot R1+4.6%
$19.79Swing high (Oct 21)+3.1%
$19.4850 day average+1.5%
$19.4020 day average+1.1%
$19.19Last close
$19.04Pivot−0.8%
$18.33Swing low (Nov 5)−4.5%
$18.14Pivot S1−5.5%
$17.68200 day average−7.9%
$6.5052 week low−66.1%
Indicators
RSI (14)
49.44
Middle of its range
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
26.5
Middle of its range
Neutral
ADX (14)
9.3
No clear trend
Williams %R
-50.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-38.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.5%
Change over 10 sessions
Bearish
ATR (14)
$1.28
Typical daily range, 6.7% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumFading
StretchNormal
VolatilityLow, 15.8%/day
Key levels
$26.0052 week high+35.5%
$20.55100 day average+7.1%
$20.08Pivot R1+4.6%
$19.79Swing high (Oct 21)+3.1%
$19.4850 day average+1.5%
$19.4020 day average+1.1%
$19.19Last close
$19.04Pivot−0.8%
$18.33Swing low (Nov 5)−4.5%
$18.14Pivot S1−5.5%
$17.68200 day average−7.9%
$6.5052 week low−66.1%
Indicators
RSI (14)
49.83
Middle of its range
Neutral
MACD
0.36
Below its signal line
Bearish
Stochastic
23.3
Middle of its range
Neutral
ADX (14)
27.6
Trending up
Williams %R
-80.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-57.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−13.9%
Change over 10 sessions
Bearish
ATR (14)
$3.03
Typical daily range, 15.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Below
What happened before, for VOR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VOR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow VOR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for VORHow many large options trades hit VOR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in VOR in the last 90 days.
From SEC Form 4 filings by VOR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VOR is in one of them and how their past VOR trades turned out.
Vor Biopharma is a biopharmaceutical company based in Boston, Massachusetts, that is developing telitacicept, a treatment for autoimmune diseases. Telitacicept is a fusion protein that acts on two signaling molecules involved in B cell activity, and the company is studying it in conditions such as generalized myasthenia gravis and Sjögren's disease. It holds rights to the drug outside Greater China and is running advanced trials aimed at approval in the United States, Europe and Japan. Its intended users are patients with autoimmune diseases and the doctors who treat them.